Michael Atchison - Publications

Affiliations: 
University of Pennsylvania, Philadelphia, PA, United States 
Area:
Molecular Biology

43/76 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Syrett CM, Paneru B, Sandoval-Heglund D, Wang J, Banerjee S, Sindhava V, Behrens EM, Atchison M, Anguera MC. Altered X-chromosome inactivation in T cells may promote sex-biased autoimmune diseases. Jci Insight. 4. PMID 30944248 DOI: 10.1172/Jci.Insight.126751  0.314
2018 Syrett CM, Sindhava V, Sierra I, Dubin AH, Atchison M, Anguera MC. Diversity of Epigenetic Features of the Inactive X-Chromosome in NK Cells, Dendritic Cells, and Macrophages. Frontiers in Immunology. 9: 3087. PMID 30671059 DOI: 10.3389/Fimmu.2018.03087  0.314
2017 Syrett CM, Sindhava V, Hodawadekar S, Myles A, Liang G, Zhang Y, Nandi S, Cancro M, Atchison M, Anguera MC. Loss of Xist RNA from the inactive X during B cell development is restored in a dynamic YY1-dependent two-step process in activated B cells. Plos Genetics. 13: e1007050. PMID 28991910 DOI: 10.1371/Journal.Pgen.1007050  0.414
2016 Banerjee A, Sindhava V, Vuyyuru R, Jha V, Hodewadekar S, Manser T, Atchison ML. YY1 Is Required for Germinal Center B Cell Development. Plos One. 11: e0155311. PMID 27167731 DOI: 10.1371/Journal.Pone.0155311  0.351
2014 Atchison ML. Function of YY1 in Long-Distance DNA Interactions. Frontiers in Immunology. 5: 45. PMID 24575094 DOI: 10.3389/fimmu.2014.00045  0.342
2014 Basu A, Wilkinson FH, Colavita K, Fennelly C, Atchison ML. YY1 DNA binding and interaction with YAF2 is essential for Polycomb recruitment. Nucleic Acids Research. 42: 2208-23. PMID 24285299 DOI: 10.1093/nar/gkt1187  0.362
2013 Pan X, Papasani M, Hao Y, Calamito M, Wei F, Quinn Iii WJ, Basu A, Wang J, Hodawadekar S, Zaprazna K, Liu H, Shi Y, Allman D, Cancro M, Atchison ML. YY1 controls Igκ repertoire and B-cell development, and localizes with condensin on the Igκ locus. The Embo Journal. 32: 1168-82. PMID 23531880 DOI: 10.1038/Emboj.2013.66  0.584
2012 Pan X, Jones M, Jiang J, Zaprazna K, Yu D, Pear W, Maillard I, Atchison ML. Increased expression of PcG protein YY1 negatively regulates B cell development while allowing accumulation of myeloid cells and LT-HSC cells. Plos One. 7: e30656. PMID 22292011 DOI: 10.1371/Journal.Pone.0030656  0.589
2012 Zaprazna K, Atchison ML. YY1 controls immunoglobulin class switch recombination and nuclear activation-induced deaminase levels. Molecular and Cellular Biology. 32: 1542-54. PMID 22290437 DOI: 10.1128/MCB.05989-11  0.383
2012 Hodawadekar S, Park K, Farrar MA, Atchison ML. A developmentally controlled competitive STAT5-PU.1 DNA binding mechanism regulates activity of the Ig κ E3' enhancer. Journal of Immunology (Baltimore, Md. : 1950). 188: 2276-84. PMID 22279106 DOI: 10.4049/Jimmunol.1102239  0.378
2011 Atchison M, Basu A, Zaprazna K, Papasani M. Mechanisms of Yin Yang 1 in oncogenesis: the importance of indirect effects. Critical Reviews in Oncogenesis. 16: 143-61. PMID 22248052 DOI: 10.1615/CRITREVONCOG.V16.I3-4.20  0.332
2010 Basu A, Atchison ML. CtBP levels control intergenic transcripts, PHO/YY1 DNA binding, and PcG recruitment to DNA. Journal of Cellular Biochemistry. 110: 62-9. PMID 20082324 DOI: 10.1002/jcb.22487  0.335
2010 Basu A, Hodawadekar S, Andrews O, Knox A, Pan X, Wilkinson F, Atchison ML. YY1 PcG function as a Potential cancer Therapeutic Target Forum On Immunopathological Diseases and Therapeutics. 1: 31-50. DOI: 10.1615/Forumimmundisther.V1.I1-2.30  0.464
2009 Wei F, Zaprazna K, Wang J, Atchison ML. PU.1 can recruit BCL6 to DNA to repress gene expression in germinal center B cells. Molecular and Cellular Biology. 29: 4612-22. PMID 19564417 DOI: 10.1128/MCB.00234-09  0.393
2007 Azim AC, Wang X, Park GY, Sadikot RT, Cao H, Mathew B, Atchison M, van Breemen RB, Joo M, Christman JW. NF-kappaB-inducing kinase regulates cyclooxygenase 2 gene expression in macrophages by phosphorylation of PU.1. Journal of Immunology (Baltimore, Md. : 1950). 179: 7868-75. PMID 18025233 DOI: 10.4049/Jimmunol.179.11.7868  0.38
2007 Cozma D, Yu D, Hodawadekar S, Azvolinsky A, Grande S, Tobias JW, Metzgar MH, Paterson J, Erikson J, Marafioti T, Monroe JG, Atchison ML, Thomas-Tikhonenko A. B cell activator PAX5 promotes lymphomagenesis through stimulation of B cell receptor signaling. The Journal of Clinical Investigation. 117: 2602-10. PMID 17717600 DOI: 10.1172/Jci30842  0.33
2007 Wei F, Schöler HR, Atchison ML. Sumoylation of Oct4 enhances its stability, DNA binding, and transactivation. The Journal of Biological Chemistry. 282: 21551-60. PMID 17525163 DOI: 10.1074/jbc.M611041200  0.35
2007 Hodawadekar S, Yu D, Cozma D, Freedman B, Sunyer O, Atchison ML, Thomas-Tikhonenko A. B-Lymphoma cells with epigenetic silencing of Pax5 trans-differentiate into macrophages, but not other hematopoietic lineages. Experimental Cell Research. 313: 331-40. PMID 17098231 DOI: 10.1016/J.Yexcr.2006.10.015  0.372
2006 Hodawadekar S, Wei F, Yu D, Thomas-Tikhonenko A, Atchison ML. Epigenetic histone modifications do not control Igkappa locus contraction and intranuclear localization in cells with dual B cell-macrophage potential. Journal of Immunology (Baltimore, Md. : 1950). 177: 6165-71. PMID 17056545 DOI: 10.4049/Jimmunol.177.9.6165  0.357
2005 Bai Y, Srinivasan L, Perkins L, Atchison ML. Protein acetylation regulates both PU.1 transactivation and Ig kappa 3' enhancer activity. Journal of Immunology (Baltimore, Md. : 1950). 175: 5160-9. PMID 16210620 DOI: 10.4049/JIMMUNOL.175.8.5160  0.353
2005 Srinivasan L, Pan X, Atchison ML. Transient requirements of YY1 expression for PcG transcriptional repression and phenotypic rescue. Journal of Cellular Biochemistry. 96: 689-99. PMID 16052488 DOI: 10.1002/Jcb.20562  0.553
2005 McDevit DC, Perkins L, Atchison ML, Nikolajczyk BS. The Ig kappa 3' enhancer is activated by gradients of chromatin accessibility and protein association. Journal of Immunology (Baltimore, Md. : 1950). 174: 2834-42. PMID 15728493 DOI: 10.4049/Jimmunol.174.5.2834  0.369
2004 Boopathi E, Lenka N, Prabu SK, Fang JK, Wilkinson F, Atchison M, Giallongo A, Avadhani NG. Regulation of murine cytochrome c oxidase Vb gene expression during myogenesis: YY-1 and heterogeneous nuclear ribonucleoprotein D-like protein (JKTBP1) reciprocally regulate transcription activity by physical interaction with the BERF-1/ZBP-89 factor. The Journal of Biological Chemistry. 279: 35242-54. PMID 15190078 DOI: 10.1074/Jbc.M403160200  0.433
2003 Atchison L, Ghias A, Wilkinson F, Bonini N, Atchison ML. Transcription factor YY1 functions as a PcG protein in vivo. The Embo Journal. 22: 1347-58. PMID 12628927 DOI: 10.1093/emboj/cdg124  0.348
2003 Yu D, Allman D, Goldschmidt MH, Atchison ML, Monroe JG, Thomas-Tikhonenko A. Oscillation between B-lymphoid and myeloid lineages in Myc-induced hematopoietic tumors following spontaneous silencing/reactivation of the EBF/Pax5 pathway. Blood. 101: 1950-5. PMID 12406913 DOI: 10.1182/Blood-2002-06-1797  0.364
2002 Nagulapalli S, Goheer A, Pitt L, McIntosh LP, Atchison ML. Mechanism of e47-Pip interaction on DNA resulting in transcriptional synergy and activation of immunoglobulin germ line sterile transcripts. Molecular and Cellular Biology. 22: 7337-50. PMID 12242308 DOI: 10.1128/Mcb.22.20.7337-7350.2002  0.364
2002 Hong W, Kim AY, Ky S, Rakowski C, Seo SB, Chakravarti D, Atchison M, Blobel GA. Inhibition of CBP-mediated protein acetylation by the Ets family oncoprotein PU.1 Molecular and Cellular Biology. 22: 3729-3743. PMID 11997509 DOI: 10.1128/Mcb.22.11.3729-3743.2002  0.409
2000 Maitra S, Atchison M. BSAP can repress enhancer activity by targeting PU.1 function. Molecular and Cellular Biology. 20: 1911-22. PMID 10688639 DOI: 10.1128/Mcb.20.6.1911-1922.2000  0.623
1998 Nagulapalli S, Atchison ML. Transcription factor Pip can enhance DNA binding by E47, leading to transcriptional synergy involving multiple protein domains. Molecular and Cellular Biology. 18: 4639-50. PMID 9671474 DOI: 10.1128/MCB.18.8.4639  0.314
1998 Fisher RC, Olson MC, Pongubala JMR, Perkel JM, Atchison ML, Scott EW, Simon MC. Normal myeloid development requires both the glutaminerich transactivation domain and the PEST region of transcription factor PU.1 but not the potent acidic transactivation domain Molecular and Cellular Biology. 18: 4347-4357. PMID 9632818 DOI: 10.1128/Mcb.18.7.4347  0.307
1997 Zhang C, Gadue P, Scott E, Atchison M, Poncz M. Activation of the megakaryocyte-specific gene platelet basic protein (PBP) by the Ets family factor PU.1. The Journal of Biological Chemistry. 272: 26236-46. PMID 9334192 DOI: 10.1074/Jbc.272.42.26236  0.437
1997 Pongubala JM, Atchison ML. PU.1 can participate in an active enhancer complex without its transcriptional activation domain. Proceedings of the National Academy of Sciences of the United States of America. 94: 127-32. PMID 8990172 DOI: 10.1073/pnas.94.1.127  0.312
1995 Pongubala JM, Atchison ML. Activating transcription factor 1 and cyclic AMP response element modulator can modulate the activity of the immunoglobulin kappa 3' enhancer. The Journal of Biological Chemistry. 270: 10304-13. PMID 7730336 DOI: 10.1074/jbc.270.17.10304  0.318
1993 Pongubala JMR, Van Beveren C, Nagulapalli S, Klemsz MJ, McKercher SR, Maki RA, Atchison ML. Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation Science. 259: 1622-1625. PMID 8456286 DOI: 10.1126/Science.8456286  0.371
1993 Satyamoorthy K, Park K, Atchison ML, Howe CC. The intracisternal A-particle upstream element interacts with transcription factor YY1 to activate transcription: pleiotropic effects of YY1 on distinct DNA promoter elements. Molecular and Cellular Biology. 13: 6621-8. PMID 8413258 DOI: 10.1128/MCB.13.11.6621  0.3
1992 Pongubala JMR, Nagulapalli S, Klemsz MJ, McKercher SR, Maki RA, Atchison ML. PU.1 recruits a second nuclear factor to a site important for immunoglobulin κ 3′ enhancer activity Molecular and Cellular Biology. 12: 368-378. PMID 1729611  0.312
1991 Park K, Atchison ML. Isolation of a candidate repressor/activator, NF-E1 (YY-1, delta), that binds to the immunoglobulin kappa 3' enhancer and the immunoglobulin heavy-chain mu E1 site. Proceedings of the National Academy of Sciences of the United States of America. 88: 9804-8. PMID 1946405 DOI: 10.1073/pnas.88.21.9804  0.302
1991 Pongubala JM, Atchison ML. Functional characterization of the developmentally controlled immunoglobulin kappa 3' enhancer: regulation by Id, a repressor of helix-loop-helix transcription factors. Molecular and Cellular Biology. 11: 1040-7. PMID 1899281 DOI: 10.1128/MCB.11.2.1040  0.384
1989 Atchison ML, Meyuhas O, Perry RP. Localization of transcriptional regulatory elements and nuclear factor binding sites in mouse ribosomal protein gene rpL32. Molecular and Cellular Biology. 9: 2067-74. PMID 2546059 DOI: 10.1128/MCB.9.5.2067  0.322
1988 Kelley DE, Pollok BA, Atchison ML, Perry RP. The coupling between enhancer activity and hypomethylation of kappa immunoglobulin genes is developmentally regulated. Molecular and Cellular Biology. 8: 930-7. PMID 3127693 DOI: 10.1128/MCB.8.2.930  0.363
1987 Atchison ML, Perry RP. The role of the kappa enhancer and its binding factor NF-kappa B in the developmental regulation of kappa gene transcription. Cell. 48: 121-8. PMID 3098435 DOI: 10.1016/0092-8674(87)90362-X  0.367
1986 Atchison M, Adesnik M. Gene conversion in a cytochrome P-450 gene family Proceedings of the National Academy of Sciences of the United States of America. 83: 2300-2304. PMID 3458196 DOI: 10.1073/Pnas.83.8.2300  0.331
1986 Atchison ML, Perry RP. Tandem kappa immunoglobulin promoters are equally active in the presence of the kappa enhancer: implications for models of enhancer function. Cell. 46: 253-62. PMID 3087628 DOI: 10.1016/0092-8674(86)90742-7  0.31
Low-probability matches (unlikely to be authored by this person)
1986 Mentaberry A, Adesnik M, Atchison M, NorgÃ¥rd EM, Alvarez F, Sabatini DD, Colman DR. Small basic proteins of myelin from central and peripheral nervous systems are encoded by the same gene. Proceedings of the National Academy of Sciences of the United States of America. 83: 1111-4. PMID 2419899 DOI: 10.1073/Pnas.83.4.1111  0.29
1996 Bushmeyer S, Park K, Atchison ML. Characterization of functional domains within the multifunctional transcription factor, YY1. The Journal of Biological Chemistry. 270: 30213-20. PMID 8530432 DOI: 10.1074/jbc.270.50.30213  0.286
1992 Gualberto A, LePage D, Pons G, Mader SL, Park K, Atchison ML, Walsh K. Functional antagonism between YY1 and the serum response factor. Molecular and Cellular Biology. 12: 4209-14. PMID 1508214 DOI: 10.1128/MCB.12.9.4209  0.281
1988 Atchison ML, Perry RP. Complementation between two cell lines lacking kappa enhancer activity: implications for the developmental control of immunoglobulin transcription. The Embo Journal. 7: 4213-4220. DOI: 10.1002/j.1460-2075.1988.tb03318.x  0.271
2022 Lee AC, Pingali SR, Pinilla-Ibarz JA, Atchison ML, Koumenis C, Argon Y, Thomas-Tikhonenko A, De Trez C, Hu CA, Tang CA. Loss of AID exacerbates the malignant progression of CLL. Leukemia. PMID 36042317 DOI: 10.1038/s41375-022-01663-5  0.271
1996 Costa MW, Atchison ML. Identification of an Spl-like element within the immunoglobulin kappa 3' enhancer necessary for maximal enhancer activity. Biochemistry. 35: 8662-9. PMID 8679628 DOI: 10.1021/bi952801y  0.264
1987 Friedberg T, Waxman DJ, Atchison M, Kumar A, Haaparanta T, Raphael C, Adesnik M. Isolation and characterization of cDNA clones for cytochromes P-450 immunochemically related to rat hepatic P-450 form PB-1. Biochemistry. 25: 7975-83. PMID 3801454 DOI: 10.1021/Bi00372A028  0.262
1985 Atchison M, Atchison ML, Van Duuren BL. Cocarcinogenesis in vitro using Balb/3T3 cells and aromatic hydrocarbon cocarcinogens. Cell Biology and Toxicology. 1: 323-31. PMID 3916990 DOI: 10.1007/Bf00118197  0.259
1998 McNeil S, Guo B, Stein JL, Lian JB, Bushmeyer S, Seto E, Atchison ML, Penman S, van Wijnen AJ, Stein GS. Targeting of the YY1 transcription factor to the nucleolus and the nuclear matrix in situ: the C-terminus is a principal determinant for nuclear trafficking. Journal of Cellular Biochemistry. 68: 500-10. PMID 9493912 DOI: 10.1002/(Sici)1097-4644(19980315)68:4<500::Aid-Jcb9>3.0.Co;2-U  0.256
1990 Atchison L, Cannizzaro L, Caamano J, Atchison M, Comis RL. Assignment of 35 single-copy and 17 repetitive sequence DNA probes to human chromosome 3: high-resolution physical mapping of 7 DNA probes by in situ hybridization. Genomics. 6: 441-50. PMID 2328989 DOI: 10.1016/0888-7543(90)90474-9  0.254
1998 Bushmeyer SM, Atchison ML. Identification of YY1 sequences necessary for association with the nuclear matrix and for transcriptional repression functions. Journal of Cellular Biochemistry. 68: 484-99. PMID 9493911 DOI: 10.1002/(SICI)1097-4644(19980315)68:4<484::AID-JCB8>3.0.CO;2-M  0.252
2020 Derleth MR, Avila A, Atchison M, Basu A. Interplay of YY1 and CtBP in the recruitment of PcG complexes to DNA. The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.03988  0.25
2004 Srinivasan L, Atchison ML. YY1 DNA binding and PcG recruitment requires CtBP. Genes & Development. 18: 2596-601. PMID 15520279 DOI: 10.1101/gad.1228204  0.245
2018 Zaprazna K, Reblova K, Svobodova V, Radova L, Bystry V, Baloun J, Durechova K, Tom N, Loja T, Buresova M, Stranska K, Oltova A, Doubek M, Atchison ML, Trbusek M, et al. Activation-induced deaminase and its splice variants associate with trisomy 12 in chronic lymphocytic leukemia. Annals of Hematology. PMID 30368590 DOI: 10.1007/s00277-018-3520-5  0.245
2020 Nandi S, Liang G, Sindhava V, Angireddy R, Basu A, Banerjee S, Hodawadekar S, Zhang Y, Avadhani NG, Sen R, Atchison ML. YY1 Control of Mitochondrial-Related Genes does not Account for Regulation of Immunoglobulin Class Switch Recombination in mice. European Journal of Immunology. PMID 32092784 DOI: 10.1002/Eji.201948385  0.244
2004 Joo M, Park GY, Wright JG, Blackwell TS, Atchison ML, Christman JW. Transcriptional regulation of the cyclooxygenase-2 gene in macrophages by PU.1. The Journal of Biological Chemistry. 279: 6658-65. PMID 14966110 DOI: 10.1074/Jbc.M306267200  0.239
2016 Wang J, Syrett CM, Kramer MC, Basu A, Atchison ML, Anguera MC. Unusual maintenance of X chromosome inactivation predisposes female lymphocytes for increased expression from the inactive X. Proceedings of the National Academy of Sciences of the United States of America. PMID 27001848 DOI: 10.1073/Pnas.1520113113  0.228
1988 Perry RP, Atchison ML, Kelley DE, Peterson ML. Transcriptional and processing-level control of immunoglobulin gene expression Annals of the New York Academy of Sciences. 546: 25-33. PMID 3073696 DOI: 10.1111/j.1749-6632.1988.tb21615.x  0.215
2007 Calame K, Atchison M. YY1 helps to bring loose ends together. Genes & Development. 21: 1145-52. PMID 17504933 DOI: 10.1101/Gad.1559007  0.209
2017 Zaprazna K, Basu A, Tom N, Jha V, Hodawadekar S, Radova L, Malcikova J, Tichy B, Pospisilova S, Atchison ML. Transcription factor YY1 can control AID-mediated Mutagenesis in mice. European Journal of Immunology. PMID 29080214 DOI: 10.1002/eji.201747065  0.198
1989 Atchison ML. Enhancers: mechanisms of action and cell specificity. Annual Review of Cell Biology. 4: 127-53. PMID 2848550 DOI: 10.1146/annurev.cb.04.110188.001015  0.194
2020 Qiu X, Ma F, Zhao M, Cao Y, Shipp L, Liu A, Dutta A, Singh A, Braikia FZ, De S, Wood WH, Becker KG, Zhou W, Ji H, Zhao K, ... Atchison ML, et al. Altered 3D chromatin structure permits inversional recombination at the locus. Science Advances. 6: eaaz8850. PMID 32851160 DOI: 10.1126/Sciadv.Aaz8850  0.187
2005 Atchison M. VMSTP Combined Degree Training (VMD/PhD): key features of the program at the University of Pennsylvania. Journal of Veterinary Medical Education. 32: 337-41. PMID 16261494 DOI: 10.3138/Jvme.32.3.337  0.179
2006 Wilkinson FH, Park K, Atchison ML. Polycomb recruitment to DNA in vivo by the YY1 REPO domain. Proceedings of the National Academy of Sciences of the United States of America. 103: 19296-301. PMID 17158804 DOI: 10.1073/pnas.0603564103  0.173
1995 Atchison L, Comis RL, Atchison ML. Construction of human chromosome-3-specific radiation hybrids and characterization by Alu-PCR. Gene. 151: 321-4. PMID 7828898 DOI: 10.1016/0378-1119(94)90678-5  0.172
1990 Atchison ML, Delmas V, Perry RP. A novel upstream element compensates for an ineffectual octamer motif in an immunoglobulin V kappa promoter. The Embo Journal. 9: 3109-3117. DOI: 10.1002/j.1460-2075.1990.tb07508.x  0.168
2016 Mehra P, Gerasimova T, Basu A, Jha V, Banerjee A, Sindhava V, Gray F, Berry CT, Sen R, Atchison ML. YY1 controls Eμ-3'RR DNA loop formation and immunoglobulin heavy chain class switch recombination. Blood Advances. 1: 15-20. PMID 29167838 DOI: 10.1182/Bloodadvances.2016000372  0.162
1995 Atchison L, Comis RL, Atchison ML. Construction of rare restriction site (NotI, SacII and ClaI) linking libraries and sequence-tagged site analysis of single-copy clones from a human chromosome-3-specific library. Gene. 151: 325-8. PMID 7828899 DOI: 10.1016/0378-1119(94)90679-3  0.153
2010 Wilkinson F, Pratt H, Atchison ML. PcG recruitment by the YY1 REPO domain can be mediated by Yaf2. Journal of Cellular Biochemistry. 109: 478-86. PMID 19960508 DOI: 10.1002/jcb.22424  0.133
1995 Atchison L, Atchison ML, Cannizzaro LA. High-resolution mapping of 10 unique DNA sequences to human chromosome 3 subregions by in situ hybridization. Cytogenetics and Cell Genetics. 71: 136-8. PMID 7656582 DOI: 10.1159/000134092  0.117
1978 Kimelberg HK, Atchison ML. EFFECTS OF ENTRAPMENT IN LIPOSOMES ON THE DISTRIBUTION, DEGRADATION AND EFFECTIVENESS OF METHOTREXATE IN VIVO Annals of the New York Academy of Sciences. 308: 395-410. PMID 100041 DOI: 10.1111/j.1749-6632.1978.tb22037.x  0.052
2009 Atchison ML. Factors that attract veterinarians to or discourage them from research careers: a program director's perspective. Journal of Veterinary Medical Education. 36: 76-82. PMID 19435993 DOI: 10.3138/jvme.36.1.76  0.046
2009 Buss DD, Atchison ML, Corps KN, Falkowski LB, Fox JG, Hendricks JC, Mexas AM, Rosol TJ, Stromberg BE. Veterinarians in biomedical research: building national capacity. Journal of Veterinary Medical Education. 36: 62-9. PMID 19435991 DOI: 10.3138/Jvme.36.1.62  0.026
Hide low-probability matches.